Zobrazeno 1 - 10
of 793
pro vyhledávání: '"Giuseppe GIACCONE"'
Autor:
Isabella Sala, Eleonora Pagan, Laura Pala, Chiara Oriecuia, Marco Musca, Claudia Specchia, Tommaso De Pas, Javier Cortes, Giuseppe Giaccone, Michael Postow, Richard D. Gelber, Vincenzo Bagnardi, Fabio Conforti
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThere is debate on which are the best surrogate endpoint and metric to capture treatment effect on overall survival (OS) in RCTs testing immune-checkpoint inhibitors (ICIs).MethodsWe systematically searched for RCTs testing ICIs in patien
Externí odkaz:
https://doaj.org/article/41a1befd79f048e8a9b532a6878b8f02
Autor:
Robert Johnston, Hartmut Koeppen, Roy S Herbst, Kurt Schalper, Filippo De Marinis, Giuseppe Giaccone, Jacek Jassem, Marcus Ballinger, Barani Kumar Rajendran, David R Spigel, Miguel López de Rodas, Minu K Srivastava, Jennifer M Giltnane, Barzin Y Nabet, David S Shames, Velimir Gayevskiy, Vy Ma, Ivette Estay, Tien Hoang, Reena Amin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/49316787c82b4055a76f2b4631e47f3f
Autor:
Yosuke Yamada, Djeda Belharazem-Vitacolonnna, Hanibal Bohnenberger, Christel Weiß, Naoko Matsui, Mark Kriegsmann, Katharina Kriegsmann, Peter Sinn, Katja Simon-Keller, Gerhard Hamilton, Thomas Graeter, Gerhard Preissler, German Ott, Sebastian Schölch, Naoki Nakajima, Akihiko Yoshizawa, Hironori Haga, Hiroshi Date, Roman K. Thomas, Iacopo Petrini, Giuseppe Giaccone, Philipp Ströbel, Alexander Marx
Publikováno v:
Cell Death and Disease, Vol 13, Iss 11, Pp 1-11 (2022)
Abstract Tuft cells are chemosensory epithelial cells in the respiratory tract and several other organs. Recent studies revealed tuft cell-like gene expression signatures in some pulmonary adenocarcinomas, squamous cell carcinomas (SQCC), small cell
Externí odkaz:
https://doaj.org/article/aaade6c0d522458ea3d812565b5a42cc
Autor:
Michael Carrasquilla, MD, Nitika Paudel, MD, PhD, Brian T. Collins, MD, Eric Anderson, MD, Rebecca Krochmal, MD, Marc Margolis, MD, Ahssan Balawi, MS, CMD, David DeBlois, BS, CMD, Giuseppe Giaccone, MD, PhD, Chul Kim, MD, Stephen Liu, MD, Jonathan W. Lischalk, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 2, Pp 101125- (2023)
Purpose: Non-small cell lung cancer (NSCLC) is a deadly malignancy that is frequently diagnosed in patients with significant medical comorbidities. When delivering local and regional therapy, an exceedingly narrow therapeutic window is encountered, w
Externí odkaz:
https://doaj.org/article/504baaa9713e45d39d5274ba6ff27bfc
Autor:
Sarah Martinez Roth, Eveline E. Vietsch, Megan E. Barefoot, Marcel O. Schmidt, Matthew D. Park, Archana Ramesh, Michael R. Lindberg, Giuseppe Giaccone, Anna T. Riegel, Ana Barac, Keith Unger, Anton Wellstein
Publikováno v:
Gastrointestinal Disorders, Vol 3, Iss 3, Pp 100-112 (2021)
Thoracic high-dose radiation therapy (RT) for cancer has been associated with early and late cardiac toxicity. To assess altered rates of cardiomyocyte cell death due to RT we monitored changes in cardiomyocyte-specific, cell-free methylated DNA (cfD
Externí odkaz:
https://doaj.org/article/44f090ede39b42859e5a5e78d9c4ff96
Autor:
Xiaoliang Zhao, In‐Kyu Kim, Bhaskar Kallakury, Joeffrey J. Chahine, Eiji Iwama, Mariaelena Pierobon, Emanuel Petricoin, Justine N. McCutcheon, Yu‐Wen Zhang, Shigeki Umemura, Vincent Chen, Changli Wang, Giuseppe Giaccone
Publikováno v:
Molecular Oncology, Vol 15, Iss 4, Pp 1130-1145 (2021)
Platinum‐based chemotherapy has been the cornerstone treatment for small cell lung cancer (SCLC) for decades, but no major progress has been made in the past 20 years with regard to overcoming chemoresistance. As the cell cycle checkpoint kinase 1
Externí odkaz:
https://doaj.org/article/e995781752ad4beab13c6c3af65e4fac
Autor:
Mariaelena Pierobon, Johann De Bono, Ruth Riisnaes, Giuseppe Giaccone, Matthew Blackburn, Lance Liotta, Vienna Ludovini, Neil J Shah, Giuseppina Improta, Antonella Ravaggi, Niven Mehra, Angelo Sidoni, Elisa Baldelli, K Alex Hodge, Guido Bellezza, Guido Gambara, Martina Mandarano, Chamodya Ruhunusiri, Bryant Dunetz, Maysa Abu-Khalaf, Julia Wulfkuhle, Rosa I Gallagher, Franco Odicino, Maria Isabella Sereni, Angela Zupa, Perry Demsko, Lucio Crino', Emanuel F Petricoin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/b20bc5349766429ca47d7ba6932e2280
Autor:
Chul Kim, Stephen V. Liu, Jennifer Crawford, Tisdrey Torres, Vincent Chen, Jillian Thompson, Ming Tan, Giuseppe Esposito, Deepa S. Subramaniam, Giuseppe Giaccone
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundOsimertinib is an effective first-line therapy option for EGFR-mutant NSCLC, but virtually all patients develop resistance. CRIPTO, through Src activation, has been implicated in resistance to EGFR tyrosine kinase inhibitor (EGFR-TKI) thera
Externí odkaz:
https://doaj.org/article/9e4a8042f8624faea5878ab1f95c2486
Publikováno v:
Cell Reports Medicine, Vol 2, Iss 9, Pp 100392- (2021)
Summary: Thymic carcinoma is rare and has a poorer prognosis than thymomas. The treatment options are limited after failure of platinum-based chemotherapy. We previously performed a single-center phase II study of pembrolizumab in patients with advan
Externí odkaz:
https://doaj.org/article/3e2800ac9c4040ac903a323a733f7b6d
Autor:
Roy Herbst, Jacek Jassem, Seye Abogunrin, Daniel James, Rachael McCool, Rossella Belleli, Giuseppe Giaccone, Filippo De Marinis
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
In the absence of head-to-head trials of first-line treatments for metastatic non-small cell lung cancer (NSCLC), synthesis of available evidence is needed. We conducted a systematic literature review and network meta-analysis of randomized controlle
Externí odkaz:
https://doaj.org/article/636b19e19c254784bf5addb057bce607